Position in MRK
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$1,039,436
+$14,806 QoQ
Shares Held
8,089
-5.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#2,089
of 3,769 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cooper Financial Group holds $19,451,562 across 11 Drug Manufacturers - General names. MRK ranks #6 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,274 | $6,325,794 | |
| 2 | AMGN |
Amgen Inc
|
8,265 | $2,992,921 | |
| 3 | ABBV |
AbbVie Inc.
|
11,460 | $2,883,794 | |
| 4 | JNJ |
Johnson & Johnson
|
10,851 | $2,755,828 | |
| 5 | AZN |
Astrazeneca PLC
|
6,342 | $1,202,570 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
8,089 | $1,039,436 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
12,387 | $713,738 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,403 | $556,275 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,039,436 | 8,089 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $1,024,630 | 8,518 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $688,400 | 6,540 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $494,431 | 5,891 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $367,144 | 4,638 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $570,155 | 6,352 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $612,498 | 6,157 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $595,962 | 5,248 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $982,972 | 7,940 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $1,012,056 | 7,670 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $788,214 | 7,230 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $732,077 | 7,111 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $851,578 | 7,380 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $799,946 | 7,519 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $703,533 | 6,341 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $453,594 | 5,267 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $414,823 | 4,550 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $248,201 | 3,025 | Shares | Sole | 2022-04-25 | |
| 2021-09-30 | $234,192 | 3,118 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $236,343 | 3,039 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $397,553 | 5,157 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $764,257 | 9,343 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $327,486 | 3,948 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $210,337 | 2,720 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $205,121 | 2,666 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||